Platelet rich plasma (PRP) is a concentrate mixture of platelet rich plasma protein derived from blood using the centrifugation method. Platelets are blood clotting cells and have the ability of healing of ligaments, tendons, and muscles at a rapid pace.
It can be utilized in numerous application areas, including cosmetic surgery, wound healing, dentistry, orthopedics, neurosurgery, and ophthalmology.
Preparation of Concentrated PRP
Blood extracted from a patient is placed in a centrifuge to separate platelets. The derived platelets are then injected into or around the injured area for quicker healing. The standard protocol for PRP involves addition of an Anti-Coagulant (ACD) to avoid blood clotting. Since an individual’s own blood is utilized in the process, there is no risk of infection and allergic reactions. Red blood cells (RBC) and neutrophils are removed from pure PRP as they contain inflammatory components and do not have healing properties.
EmCyte Corporation has developed a PurePRP SupraPhysiologic concentrating device. This device is intended for safe and quick processing. The closed system aids in preventing exposure of biologics to ambient air throughout the process. The system is needleless, thus confirming the safety of the user. This product takes less than 8 minutes to complete the process and can be used within four hours of collection without losing cell viability.
Recently, DR. PRP AMERICA, LLC developed a tool called the Dr. PRP Platelet separation kit. It is utilized to collect a patient’s blood for harvesting concentrated PRP. The patient’s blood sample is moved to the kit for separation of platelets using a centrifuge. The concentration of platelets determines the efficiency of a decent separation system. The kit includes a specific filter and centrifuge speed to gain the highest platelet recovery rate, which is around 97% or more.
Market Overview
According to Grand View Research, Inc., the global platelet rich plasma (PRP) market is set to achieve around USD 647.1 million by 2025. Growing geriatric population and increasing occurrence of orthopedic ailments can boost the market.
In 2016, pure PRP led the market by product. Leukocyte-rich fibrin is projected to register the highest CAGR over the forecast period (2014 to 2025). It comprises a natural healing protein, which helps in bone regeneration and heals soft as well as hard tissues. This product is highly useful in oral and maxillofacial surgeries.
The orthopedics sector dominated the market in 2016 as many orthopedic complaints including Achilles tendon injuries, tennis elbow, quadriceps, hamstring, and rotator cuff can be treated with PRP. The dermatology and cosmetic surgery segment is predicted to experience robust growth over the forecast period due to increasing demand for PRP cosmetic surgeries. In 2016, North America dominated the market. Asia Pacific is likely to show fastest growth over the forecast period due to an expanding medical tourism industry in this region.
Prominent players operating in the market include EmCyte Corporation, DR. PRP AMERICA, LLC, Zimmer Biomet, Terumo BCT, and T-Biotechnology (T-LAB).
In-Depth research report on Platelet Rich Plasma (PRP) Market:
No comments:
Post a Comment